Volgen
Andreas Krause
Andreas Krause
Idorsia Pharmaceuticals Ltd
Geverifieerd e-mailadres voor elmo.ch
Titel
Geciteerd door
Geciteerd door
Jaar
A standard curve based method for relative real time PCR data processing
A Larionov, A Krause, W Miller
BMC bioinformatics 6, 1-16, 2005
10612005
Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole
MJ Ellis, Y Tao, O Young, S White, AD Proia, J Murray, L Renshaw, ...
Journal of clinical oncology 24 (19), 3019-3025, 2006
2212006
The Basics of S-(scPlus)
A Krause, M Olson
Springer New York, 2000
2112000
Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies
A Scherer, A Krause, JR Walker, A Korn, D Niese, F Raulf
Transplantation 75 (8), 1323-1330, 2003
1372003
Drug development for pediatric populations: regulatory aspects
J Zisowsky, A Krause, J Dingemanse
Pharmaceutics 2 (4), 364-388, 2010
1212010
Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole
WR Miller, A Larionov, L Renshaw, TJ Anderson, JR Walker, A Krause, ...
J Clin Oncol 27 (9), 1382-1387, 2009
1172009
Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole
WR Miller, AA Larionov, L Renshaw, TJ Anderson, S White, J Murray, ...
Pharmacogenetics and genomics 17 (10), 813-826, 2007
1122007
The validation of new aromatase monoclonal antibodies for immunohistochemistry—a correlation with biochemical activities in 46 cases of breast cancer
H Sasano, TJ Anderson, SG Silverberg, RJ Santen, M Conway, ...
The Journal of steroid biochemistry and molecular biology 95 (1-5), 35-39, 2005
782005
Multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P1 receptor modulator: Favorable impact of dose up‐titration
P Brossard, M Scherz, A Halabi, H Maatouk, A Krause, J Dingemanse
The Journal of Clinical Pharmacology 54 (2), 179-188, 2014
702014
Efficacy of rivastigmine in Alzheimer’s disease patients with rapid disease progression: results of a meta-analysis
MR Farlow, GW Small, P Quarg, A Krause
Dementia and geriatric cognitive disorders 20 (2-3), 192-197, 2005
692005
Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib
P Bono, A Krause, M von Mehren, MC Heinrich, CD Blanke, S Dimitrijevic, ...
Blood 103 (8), 2929-2935, 2004
652004
Optimized protocol for linear RNA amplification and application to gene expression profiling of human renal biopsies
A Scherer, A Krause, JR Walker, SE Sutton, D Seron, F Raulf, MP Cooke
Biotechniques 34 (3), 546-556, 2003
582003
Biomarker‐guided clinical development of the first‐in‐class anti‐inflammatory FPR2/ALX agonist ACT‐389949
AK Stalder, D Lott, DS Strasser, HG Cruz, A Krause, P Groenen, ...
British journal of clinical pharmacology 83 (3), 476-486, 2017
572017
Identifying interesting genes with siggenes
H Schwender, A Krause, K Ickstadt
The Newsletter of the R Project Volume 6/5, December 2006 6, 45, 2006
492006
A New Reversible and Potent P2Y12 Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial
D Baldoni, S Bruderer, A Krause, M Gutierrez, P Gueret, B Astruc, ...
Clinical drug investigation 34 (11), 807-818, 2014
482014
An integrated view of aromatase and its inhibition
WR Miller, TJ Anderson, DB Evans, A Krause, G Hampton, JM Dixon
The Journal of steroid biochemistry and molecular biology 86 (3-5), 413-421, 2003
482003
Visualization and communication of pharmacometric models with Berkeley Madonna
A Krause, PJ Lowe
CPT: pharmacometrics & systems pharmacology 3 (5), 1-20, 2014
452014
Testing numerical reliability of data analysis systems
G Sawitzki
441994
Modeling of Discontinuous Relationships in Biology with Censored Regression
B Schmid, W Polasek, J Weiner, A Krause, P Stoll
The American Naturalist 143 (3), 494-507, 1994
421994
Confidence and Prediction Intervals for Pharmacometric Models
A Kümmel, PL Bonate, J Dingemanse, A Krause
CPT: pharmacometrics & systems pharmacology 7 (6), 360-373, 2018
402018
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20